A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas

Yazmin Odia, Fabio M. Iwamoto, Argirios Moustakas, Tyler J. Fraum, Carlos A. Salgado, Aiguo Li, Teri N. Kreisl, Joohee Sul, John A. Butman, Howard A. Fine

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas'. Together they form a unique fingerprint.

Medicine & Life Sciences